246 related articles for article (PubMed ID: 6969728)
1. Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man.
Hahn TJ; Halstead LR; Baran DT
J Clin Endocrinol Metab; 1981 Jan; 52(1):111-5. PubMed ID: 6969728
[TBL] [Abstract][Full Text] [Related]
2. Effect of growth hormone administration: reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption.
Chipman JJ; Zerwekh J; Nicar M; Marks J; Pak CY
J Clin Endocrinol Metab; 1980 Aug; 51(2):321-4. PubMed ID: 6249837
[TBL] [Abstract][Full Text] [Related]
3. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
Klein RG; Arnaud SB; Gallagher JC; Deluca HF; Riggs BL
J Clin Invest; 1977 Jul; 60(1):253-9. PubMed ID: 874087
[TBL] [Abstract][Full Text] [Related]
4. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
[TBL] [Abstract][Full Text] [Related]
6. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
Gallagher JC; Riggs BL; Eisman J; Hamstra A; Arnaud SB; DeLuca HF
J Clin Invest; 1979 Sep; 64(3):729-36. PubMed ID: 468987
[TBL] [Abstract][Full Text] [Related]
7. Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3.
Bouillon R; Muls E; De Moor P
J Clin Endocrinol Metab; 1980 Oct; 51(4):793-7. PubMed ID: 6893457
[TBL] [Abstract][Full Text] [Related]
8. The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism.
Breslau NA; McGuire JL; Zerwekh JE; Pak CY
J Clin Endocrinol Metab; 1982 Aug; 55(2):369-73. PubMed ID: 6896338
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
Chesney RW; Hamstra A; Rose P; DeLuca HF
Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
[TBL] [Abstract][Full Text] [Related]
10. Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic.
Frazer TE; White NH; Hough S; Santiago JV; McGee BR; Bryce G; Mallon J; Avioli LV
J Clin Endocrinol Metab; 1981 Dec; 53(6):1154-9. PubMed ID: 7028772
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D metabolism in women with femoral neck fracture.
Hordon LD; Peacock M
Bone Miner; 1987 Aug; 2(5):413-26. PubMed ID: 2851340
[TBL] [Abstract][Full Text] [Related]
12. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
Gallagher JC; Riggs BL; DeLuca HF
J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D metabolites and bioactive parathyroid hormone levels during Spacelab 2.
Morey-Holton ER; Schnoes HK; DeLuca HF; Phelps ME; Klein RF; Nissenson RH; Arnaud CD
Aviat Space Environ Med; 1988 Nov; 59(11 Pt 1):1038-41. PubMed ID: 3264495
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D metabolite concentrations in vitamin D deficiency. Are calcitriol levels normal.
Chesney RW; Zimmerman J; Hamstra A; DeLuca HF; Mazees RB
Am J Dis Child; 1981 Nov; 135(11):1025-8. PubMed ID: 6271009
[TBL] [Abstract][Full Text] [Related]
15. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.
Lawoyin S; Zerwekh JE; Glass K; Pak CY
J Clin Endocrinol Metab; 1980 Mar; 50(3):593-6. PubMed ID: 6965678
[TBL] [Abstract][Full Text] [Related]
16. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
17. Administration of pharmacological amounts of 25(s),26-dihydroxyvitamin D3 reduces serum 1,25-dihydroxyvitamin D3 levels in rats.
Zerwekh JE; Harvey JA; Pak CY
Endocrinology; 1987 Nov; 121(5):1671-7. PubMed ID: 3665840
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis.
Findling JW; Adams ND; Lemann J; Gray RW; Thomas CJ; Tyrrell JB
J Clin Endocrinol Metab; 1982 May; 54(5):1039-44. PubMed ID: 6977549
[TBL] [Abstract][Full Text] [Related]
19. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3.
Halloran BP; Schaefer P; Lifschitz M; Levens M; Goldsmith RS
J Clin Endocrinol Metab; 1984 Dec; 59(6):1063-9. PubMed ID: 6333430
[TBL] [Abstract][Full Text] [Related]
20. Effect of dihydroxylated metabolites of vitamin D3 on calcium absorption in uraemic man.
Muirhead N; Catto GR; Gvozdanovic S; Gvozdanovic D; Edward N
Clin Sci (Lond); 1981 Dec; 61(6):723-7. PubMed ID: 6975197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
